Marisa Pertile

Title: The Innovative Contributions of Marisa Pertile

Introduction

Marisa Pertile, an accomplished inventor based in Parma, Italy, has made significant strides in the field of pharmaceuticals. With a total of three patents to her name, Pertile's work primarily focuses on the development of modified release formulations for deferiprone, a medication crucial for treating various conditions.

Latest Patents

Pertile's latest patents include innovative pharmaceutical compositions designed for oral administration in the form of coated tablets. These formulations showcase modified release properties, enabling effective drug delivery when administered as either whole or half tablets. Specifically, one patent addresses modified release tablets containing deferiprone that are suitable for twice-daily oral administration. Additionally, another patent emphasizes modified release tablets that can be taken once daily, further enhancing patient compliance and treatment effectiveness. The disclosed inventions also include methods for making and utilizing these advanced formulations.

Career Highlights

Throughout her career, Marisa Pertile has worked with reputable institutions such as Chiesi Farmaceutici S.p.A. and Università Degli Studi di Milano. Her experiences in these organizations have provided her with the necessary expertise to drive innovation in pharmaceutical applications. Pertile’s commitment to improving drug formulations underscores her role as an influential figure in pharmaceutical research and development.

Collaborations

In her journey as an inventor, Pertile has collaborated with notable professionals, including Franco Sartor and Annamaria Soliani Raschini. Their collective expertise has helped advance the projects they were involved in, contributing to the successful development of innovative pharmaceutical solutions.

Conclusion

Marisa Pertile's contributions to the field of pharmaceuticals highlight the importance of innovation in improving treatment modalities for patients. With her three patents focused on deferiprone formulations, Pertile continues to pave the way for enhanced pharmaceutical therapies, ultimately making a significant impact on patient care and medication management.